An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A ...

Anderson Diagnostics is bringing its diagnostic services to Bangalore, opening a new processing centre outside Tamil Nadu.

Inherited or genetic heart disorders, mostly known as Hypertrophic cardiomyopathy (HCM) in medical term, is a condition affecting the left ventricle, the main p ...

Various corners of the media and internet are hyperventilating over the alleged genetic privacy implications of the imminent ...

Expert and Family Heart Foundation Ambassador Discuss the Genetic Risks of High Lipoprotein(a) and How Individuals Can Access Free At-Home Screening & Support Through Cholesterol Connect Program NEW ...

Congenital heart disease (CHD) is one of the most common birth defects, but the full extent of its genetic underpinnings has ...

Nucleus Genomics claims to give couples a picture of their combined risk for passing down hundreds of conditions to their ...

Genetic testing for hereditary arrhythmia and cardiomyopathy in an area with known founder effects on local genetic variants had a high yield in identification of pathogenic variants by taking ...